Earnings Feed
Start Free
Home/Filings/4/0001140361-15-038096
4//SEC Filing

ORAMED PHARMACEUTICALS INC. 4

Accession 0001140361-15-038096

$ORMPCIK 0001176309operating
View on SEC.govCompany Profile

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 5:09 PM ET

Size

21.3 KB

Accession

0001140361-15-038096

Insider Transaction Report

Form 4
Period: 2015-10-16
ORAMED PHARMACEUTICALS INC.ORMP
Slager David Mark
10% Owner
Transactions
  • Purchase

    Call Option (Right to Buy)

    2015-10-16$1.18/sh+1,192$1,410→ 1,192 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-16Exp: 2016-05-20→ Common Stock (119,200 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-19$1.18/sh+600$710→ 1,792 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-19Exp: 2016-05-20→ Common Stock (60,000 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-20$2.00/sh+11$22→ 1,803 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-20Exp: 2016-05-20→ Common Stock (1,100 underlying)
Holdings

  • Common Stock

    (indirect: By Regals Fund LP)
    896,364
Regals Fund LP
10% Owner
Transactions
  • Purchase

    Call Option (Right to Buy)

    2015-10-16$1.18/sh+1,192$1,410→ 1,192 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-16Exp: 2016-05-20→ Common Stock (119,200 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-20$2.00/sh+11$22→ 1,803 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-20Exp: 2016-05-20→ Common Stock (1,100 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-19$1.18/sh+600$710→ 1,792 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-19Exp: 2016-05-20→ Common Stock (60,000 underlying)
Holdings

  • Common Stock

    (indirect: By Regals Fund LP)
    896,364
REGALS CAPITAL MANAGEMENT LP
10% Owner
Transactions
  • Purchase

    Call Option (Right to Buy)

    2015-10-19$1.18/sh+600$710→ 1,792 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-19Exp: 2016-05-20→ Common Stock (60,000 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-16$1.18/sh+1,192$1,410→ 1,192 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-16Exp: 2016-05-20→ Common Stock (119,200 underlying)
  • Purchase

    Call Option (Right to Buy)

    2015-10-20$2.00/sh+11$22→ 1,803 total(indirect: By Regals Fund LP)
    Exercise: $10.00From: 2015-10-20Exp: 2016-05-20→ Common Stock (1,100 underlying)
Holdings

  • Common Stock

    (indirect: By Regals Fund LP)
    896,364
Footnotes (1)
  • [F1]This Form 4 is filed jointly by Regals Fund LP (the "Fund"), Regals Capital Management LP ("Regals Management"), and David M. Slager (collectively, the "Reporting Persons"). Mr. Slager is Managing Member of the general partner of Regals Management. Regals Management is the investment manager of the Fund. The securities reported herein are held for the account of the Fund. Accordingly, each of the Reporting Persons may be deemed to be a beneficial owner of the securities owned by the Fund for purposes of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended (the "Act"). Pursuant to Rule 16a-1(a)(4) under the Act, Regals Management and Mr. Slager disclaim beneficial ownership in the securities owned by the Fund except to the extent, if any, of their pecuniary interest therein.

Documents

2 files

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001176309

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 5:09 PM ET
Size
21.3 KB
View on SEC.gov